Bullish option flow detected in Aurinia Pharmaceuticals with 1,329 calls trading, 1.1x expected, and implied vol increasing over 6 points to 105.96%. Jan-24 12 calls and Dec-23 8 calls are the most active options, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 0.11. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia strength may be related to Gilead suspicion, says Gordon Haskett
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia Pharmaceuticals partner Otsuka files NDA in Japan for Lupkynis
- Aurinia Pharmaceuticals narrows FY23 net product revenue to $155M-$160M
- Aurinia Pharmaceuticals reports Q3 EPS (9c), consensus (17c)